Page 5 - எங்களுக்கு மையங்கள் க்கு நோய் ப்ரெவெந்ஶந் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Author Bio Keith began writing for the Fool in 2012 and focuses primarily on healthcare investing topics. His background includes serving in management and consulting for the healthcare technology, health insurance, medical device, and pharmacy benefits management industries. Follow @keithspeights What happened Shares of Moderna (NASDAQ:MRNA) were jumping 5.7% higher at 11:17 a.m. EDT on Friday. One potential reason behind the gain is that investors expect that Moderna will benefit from issues that Johnson & Johnson (NYSE:JNJ) are experiencing with their COVID-19 vaccines. On Wednesday, the European Medicines Agency (EMA) reported a possible link between AstraZeneca s COVID-19 vaccine and unusual blood clots. United Kingdom authorities issued a recommendation that people under age 30 receive another vaccine if possible.

United statesUnited kingdomEuropean medicines agencyUs centers for disease preventionDisease preventionEmergent biosolutionsTal zaksஒன்றுபட்டது மாநிலங்களில்ஒன்றுபட்டது கிஂக்டம்எங்களுக்கு மையங்கள் க்கு நோய் ப்ரெவெந்ஶந்நோய் ப்ரெவெந்ஶந்வெளிப்படுகிறது உயிர் தீர்வுகள்தால் ஜாக்ஸ்